Major disrupters in the pharmaceutical industry have put the spotlight on quantifying value and measuring impact. The appetite for innovation and change is strong. But the tolerance for risk is not.
Business leaders want to understand the return on new investments and target spending to the highest-impact opportunities. They’re driving demand for more accountable, data-driven marketing.
Learn more about this new era of marketing and how Syneos Health Communications is driving change in our latest report, Data-Driven Expectations.
